Cardiac Ablation Market By Product (Radiofrequency (RF) Ablators, Electrical Ablators, Cryoablation Devices, Ultrasound Ablators, Others) , By Approach (Catheter-based, Open/Surgical) By Application (Atrial Fibrillation & Flutter, Tachycardia, Others) By End Use (Hospitals, Ambulatory Surgical Centers, Cardiac Centers, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033

August 2024 | 315 pages | ID: C3472E5BF4F6EN
Allied Market Research

Abstracts

Cardiac Ablation Market Expected to Garner $8.6 Billion, Growing with a CAGR of 9.9%

Abstract: The global cardiac ablation market is expected to grow primarily due to the growing global prevalence of cardiac arrhythmias, such as atrial fibrillation and ventricular tachycardia. The market in the North America region is predicted to grow with the highest profitability.

As per the report published by Research Dive, the global cardiac ablation market was valued at $3.6 billion in 2023 and is expected to register a revenue of $8.6 billion by 2033 at a CAGR of 9.9% during the forecast period 2024-2033.

Dynamics of the Market

The rising prevalence of cardiac arrhythmias, such as atrial fibrillation and ventricular tachycardia, and the growing adoption of minimally invasive procedures are expected to make the cardiac ablation market a highly profitable one in the forecast period. The supportive government regulations & policies related to cardiac ablation procedures is predicted to propel the market forward.

However, according to market analysts, the high cost of cardiac ablation procedures & specialized equipment and the regulatory challenges & approval delays might restraint the growth of the market.

Innovations in ablation technologies, including radiofrequency, cryoablation, laser, and microwave, improving the effectiveness, safety, and precision of ablation procedures is predicted to offer numerous growth opportunities to the market in the forecast period. Moreover, the development of novel ablation techniques is expected to propel the cardiac ablation market forward in the coming period.

Key Players of the Global Cardiac Ablation Market

The major players of the market include Abbott Laboratories, Biosense Webster (Johnson & Johnson), Medtronic, Angiodynamics, Atricure, Boston Scientific Corporation, and Japan Lifeline.

What the Report Covers

In addition to the details highlighted in this description, the comprehensive final report delves into essential market aspects. These encompass a market overview, SWOT analysis, market dynamics, Porter’s five forces analysis, segmentation (key trends, regional analysis, and forecast analysis), and company profiles (including company overview, product portfolio, operating segments, strategic initiatives, and financial performance).

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• End user preferences and pain points
• Upcoming/New Entrant by Regions
• Technology Trend Analysis
• Go To Market Strategy
• Regulatory Guidelines
• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• Criss-cross segment analysis- market size and forecast
• Expanded list for Company Profiles
• Historic market data
• Key player details (including location, contact details, supplier/vendor network etc. in excel format)
• SWOT Analysis

Key Market Segments

By Product

• Radiofrequency (RF) Ablators
• Electrical Ablators
• Cryoablation Devices
• Ultrasound Ablators
• Others

By Approach

• Catheter-based
• Open/Surgical

By Application

• Atrial Fibrillation Flutter
• Tachycardia
• Others

By End Use

• Hospitals
• Ambulatory Surgical Centers
• Cardiac Centers
• Others

By Region

• North America
• U.S.
• Canada
• Mexico
• Europe
• France
• Germany
• Italy
• Spain
• UK
• Rest of Europe
• Asia-Pacific
• China
• Japan
• India
• South Korea
• Australia
• Rest of Asia-Pacific
• LAMEA
• Brazil
• South Africa
• Saudi Arabia
• UAE
• Rest of LAMEA
• Key Market Players
• Abbott Laboratories
• Medtronic
• Biosense Webster
• Angiodynamics
• Boston Scientific Corporation
• Atricure
• Japan Lifeline
• Teleflex Incorporated
• St. Jude Medical Inc
• Lepu Medical Technology (Beijing)Co., Ltd
• MicroPort Scientific Corporation

Contents

CHAPTER 1: INTRODUCTION

1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
  1.4.1. Primary Research
  1.4.2. Secondary Research
  1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

3.1. Market Definition and Scope
3.2. Key Findings
  3.2.1. Top Investment Pockets
  3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
  3.3.1. Bargaining Power of Suppliers
  3.3.2. Threat of New Entrants
  3.3.3. Threat of Substitutes
  3.3.4. Competitive Rivalry
  3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
  3.4.1. Drivers
  3.4.2. Restraints
  3.4.3. Opportunities

CHAPTER 4: CARDIAC ABLATION MARKET, BY PRODUCT

4.1. Market Overview
  4.1.1 Market Size and Forecast, By Product
4.2. Radiofrequency (RF) Ablators
  4.2.1. Key Market Trends, Growth Factors and Opportunities
  4.2.2. Market Size and Forecast, By Region
  4.2.3. Market Share Analysis, By Country
4.3. Electrical Ablators
  4.3.1. Key Market Trends, Growth Factors and Opportunities
  4.3.2. Market Size and Forecast, By Region
  4.3.3. Market Share Analysis, By Country
4.4. Cryoablation Devices
  4.4.1. Key Market Trends, Growth Factors and Opportunities
  4.4.2. Market Size and Forecast, By Region
  4.4.3. Market Share Analysis, By Country
4.5. Ultrasound Ablators
  4.5.1. Key Market Trends, Growth Factors and Opportunities
  4.5.2. Market Size and Forecast, By Region
  4.5.3. Market Share Analysis, By Country
4.6. Others
  4.6.1. Key Market Trends, Growth Factors and Opportunities
  4.6.2. Market Size and Forecast, By Region
  4.6.3. Market Share Analysis, By Country

CHAPTER 5: CARDIAC ABLATION MARKET, BY APPROACH

5.1. Market Overview
  5.1.1 Market Size and Forecast, By Approach
5.2. Catheter-based
  5.2.1. Key Market Trends, Growth Factors and Opportunities
  5.2.2. Market Size and Forecast, By Region
  5.2.3. Market Share Analysis, By Country
5.3. Open/Surgical
  5.3.1. Key Market Trends, Growth Factors and Opportunities
  5.3.2. Market Size and Forecast, By Region
  5.3.3. Market Share Analysis, By Country

CHAPTER 6: CARDIAC ABLATION MARKET, BY APPLICATION

6.1. Market Overview
  6.1.1 Market Size and Forecast, By Application
6.2. Atrial Fibrillation Flutter
  6.2.1. Key Market Trends, Growth Factors and Opportunities
  6.2.2. Market Size and Forecast, By Region
  6.2.3. Market Share Analysis, By Country
6.3. Tachycardia
  6.3.1. Key Market Trends, Growth Factors and Opportunities
  6.3.2. Market Size and Forecast, By Region
  6.3.3. Market Share Analysis, By Country
6.4. Others
  6.4.1. Key Market Trends, Growth Factors and Opportunities
  6.4.2. Market Size and Forecast, By Region
  6.4.3. Market Share Analysis, By Country

CHAPTER 7: CARDIAC ABLATION MARKET, BY END USE

7.1. Market Overview
  7.1.1 Market Size and Forecast, By End Use
7.2. Hospitals
  7.2.1. Key Market Trends, Growth Factors and Opportunities
  7.2.2. Market Size and Forecast, By Region
  7.2.3. Market Share Analysis, By Country
7.3. Ambulatory Surgical Centers
  7.3.1. Key Market Trends, Growth Factors and Opportunities
  7.3.2. Market Size and Forecast, By Region
  7.3.3. Market Share Analysis, By Country
7.4. Cardiac Centers
  7.4.1. Key Market Trends, Growth Factors and Opportunities
  7.4.2. Market Size and Forecast, By Region
  7.4.3. Market Share Analysis, By Country
7.5. Others
  7.5.1. Key Market Trends, Growth Factors and Opportunities
  7.5.2. Market Size and Forecast, By Region
  7.5.3. Market Share Analysis, By Country

CHAPTER 8: CARDIAC ABLATION MARKET, BY REGION

8.1. Market Overview
  8.1.1 Market Size and Forecast, By Region
8.2. North America
  8.2.1. Key Market Trends and Opportunities
  8.2.2. Market Size and Forecast, By Product
  8.2.3. Market Size and Forecast, By Approach
  8.2.4. Market Size and Forecast, By Application
  8.2.5. Market Size and Forecast, By End Use
  8.2.6. Market Size and Forecast, By Country
  8.2.7. U.S. Cardiac Ablation Market
    8.2.7.1. Market Size and Forecast, By Product
    8.2.7.2. Market Size and Forecast, By Approach
    8.2.7.3. Market Size and Forecast, By Application
    8.2.7.4. Market Size and Forecast, By End Use
  8.2.8. Canada Cardiac Ablation Market
    8.2.8.1. Market Size and Forecast, By Product
    8.2.8.2. Market Size and Forecast, By Approach
    8.2.8.3. Market Size and Forecast, By Application
    8.2.8.4. Market Size and Forecast, By End Use
  8.2.9. Mexico Cardiac Ablation Market
    8.2.9.1. Market Size and Forecast, By Product
    8.2.9.2. Market Size and Forecast, By Approach
    8.2.9.3. Market Size and Forecast, By Application
    8.2.9.4. Market Size and Forecast, By End Use
8.3. Europe
  8.3.1. Key Market Trends and Opportunities
  8.3.2. Market Size and Forecast, By Product
  8.3.3. Market Size and Forecast, By Approach
  8.3.4. Market Size and Forecast, By Application
  8.3.5. Market Size and Forecast, By End Use
  8.3.6. Market Size and Forecast, By Country
  8.3.7. France Cardiac Ablation Market
    8.3.7.1. Market Size and Forecast, By Product
    8.3.7.2. Market Size and Forecast, By Approach
    8.3.7.3. Market Size and Forecast, By Application
    8.3.7.4. Market Size and Forecast, By End Use
  8.3.8. Germany Cardiac Ablation Market
    8.3.8.1. Market Size and Forecast, By Product
    8.3.8.2. Market Size and Forecast, By Approach
    8.3.8.3. Market Size and Forecast, By Application
    8.3.8.4. Market Size and Forecast, By End Use
  8.3.9. Italy Cardiac Ablation Market
    8.3.9.1. Market Size and Forecast, By Product
    8.3.9.2. Market Size and Forecast, By Approach
    8.3.9.3. Market Size and Forecast, By Application
    8.3.9.4. Market Size and Forecast, By End Use
  8.3.10. Spain Cardiac Ablation Market
    8.3.10.1. Market Size and Forecast, By Product
    8.3.10.2. Market Size and Forecast, By Approach
    8.3.10.3. Market Size and Forecast, By Application
    8.3.10.4. Market Size and Forecast, By End Use
  8.3.11. UK Cardiac Ablation Market
    8.3.11.1. Market Size and Forecast, By Product
    8.3.11.2. Market Size and Forecast, By Approach
    8.3.11.3. Market Size and Forecast, By Application
    8.3.11.4. Market Size and Forecast, By End Use
  8.3.12. Rest Of Europe Cardiac Ablation Market
    8.3.12.1. Market Size and Forecast, By Product
    8.3.12.2. Market Size and Forecast, By Approach
    8.3.12.3. Market Size and Forecast, By Application
    8.3.12.4. Market Size and Forecast, By End Use
8.4. Asia-Pacific
  8.4.1. Key Market Trends and Opportunities
  8.4.2. Market Size and Forecast, By Product
  8.4.3. Market Size and Forecast, By Approach
  8.4.4. Market Size and Forecast, By Application
  8.4.5. Market Size and Forecast, By End Use
  8.4.6. Market Size and Forecast, By Country
  8.4.7. China Cardiac Ablation Market
    8.4.7.1. Market Size and Forecast, By Product
    8.4.7.2. Market Size and Forecast, By Approach
    8.4.7.3. Market Size and Forecast, By Application
    8.4.7.4. Market Size and Forecast, By End Use
  8.4.8. Japan Cardiac Ablation Market
    8.4.8.1. Market Size and Forecast, By Product
    8.4.8.2. Market Size and Forecast, By Approach
    8.4.8.3. Market Size and Forecast, By Application
    8.4.8.4. Market Size and Forecast, By End Use
  8.4.9. India Cardiac Ablation Market
    8.4.9.1. Market Size and Forecast, By Product
    8.4.9.2. Market Size and Forecast, By Approach
    8.4.9.3. Market Size and Forecast, By Application
    8.4.9.4. Market Size and Forecast, By End Use
  8.4.10. South Korea Cardiac Ablation Market
    8.4.10.1. Market Size and Forecast, By Product
    8.4.10.2. Market Size and Forecast, By Approach
    8.4.10.3. Market Size and Forecast, By Application
    8.4.10.4. Market Size and Forecast, By End Use
  8.4.11. Australia Cardiac Ablation Market
    8.4.11.1. Market Size and Forecast, By Product
    8.4.11.2. Market Size and Forecast, By Approach
    8.4.11.3. Market Size and Forecast, By Application
    8.4.11.4. Market Size and Forecast, By End Use
  8.4.12. Rest of Asia-Pacific Cardiac Ablation Market
    8.4.12.1. Market Size and Forecast, By Product
    8.4.12.2. Market Size and Forecast, By Approach
    8.4.12.3. Market Size and Forecast, By Application
    8.4.12.4. Market Size and Forecast, By End Use
8.5. LAMEA
  8.5.1. Key Market Trends and Opportunities
  8.5.2. Market Size and Forecast, By Product
  8.5.3. Market Size and Forecast, By Approach
  8.5.4. Market Size and Forecast, By Application
  8.5.5. Market Size and Forecast, By End Use
  8.5.6. Market Size and Forecast, By Country
  8.5.7. Brazil Cardiac Ablation Market
    8.5.7.1. Market Size and Forecast, By Product
    8.5.7.2. Market Size and Forecast, By Approach
    8.5.7.3. Market Size and Forecast, By Application
    8.5.7.4. Market Size and Forecast, By End Use
  8.5.8. South Africa Cardiac Ablation Market
    8.5.8.1. Market Size and Forecast, By Product
    8.5.8.2. Market Size and Forecast, By Approach
    8.5.8.3. Market Size and Forecast, By Application
    8.5.8.4. Market Size and Forecast, By End Use
  8.5.9. Saudi Arabia Cardiac Ablation Market
    8.5.9.1. Market Size and Forecast, By Product
    8.5.9.2. Market Size and Forecast, By Approach
    8.5.9.3. Market Size and Forecast, By Application
    8.5.9.4. Market Size and Forecast, By End Use
  8.5.10. UAE Cardiac Ablation Market
    8.5.10.1. Market Size and Forecast, By Product
    8.5.10.2. Market Size and Forecast, By Approach
    8.5.10.3. Market Size and Forecast, By Application
    8.5.10.4. Market Size and Forecast, By End Use
  8.5.11. Rest of LAMEA Cardiac Ablation Market
    8.5.11.1. Market Size and Forecast, By Product
    8.5.11.2. Market Size and Forecast, By Approach
    8.5.11.3. Market Size and Forecast, By Application
    8.5.11.4. Market Size and Forecast, By End Use

CHAPTER 9: COMPETITIVE LANDSCAPE

9.1. Introduction
9.2. Top Winning Strategies
9.3. Product Mapping Of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Top Player Positioning, 2023

CHAPTER 10: COMPANY PROFILES

10.1. Abbott Laboratories
  10.1.1. Company Overview
  10.1.2. Key Executives
  10.1.3. Company Snapshot
  10.1.4. Operating Business Segments
  10.1.5. Product Portfolio
  10.1.6. Business Performance
  10.1.7. Key Strategic Moves and Developments
10.2. Medtronic
  10.2.1. Company Overview
  10.2.2. Key Executives
  10.2.3. Company Snapshot
  10.2.4. Operating Business Segments
  10.2.5. Product Portfolio
  10.2.6. Business Performance
  10.2.7. Key Strategic Moves and Developments
10.3. Biosense Webster
  10.3.1. Company Overview
  10.3.2. Key Executives
  10.3.3. Company Snapshot
  10.3.4. Operating Business Segments
  10.3.5. Product Portfolio
  10.3.6. Business Performance
  10.3.7. Key Strategic Moves and Developments
10.4. Angiodynamics
  10.4.1. Company Overview
  10.4.2. Key Executives
  10.4.3. Company Snapshot
  10.4.4. Operating Business Segments
  10.4.5. Product Portfolio
  10.4.6. Business Performance
  10.4.7. Key Strategic Moves and Developments
10.5. Boston Scientific Corporation
  10.5.1. Company Overview
  10.5.2. Key Executives
  10.5.3. Company Snapshot
  10.5.4. Operating Business Segments
  10.5.5. Product Portfolio
  10.5.6. Business Performance
  10.5.7. Key Strategic Moves and Developments
10.6. Atricure
  10.6.1. Company Overview
  10.6.2. Key Executives
  10.6.3. Company Snapshot
  10.6.4. Operating Business Segments
  10.6.5. Product Portfolio
  10.6.6. Business Performance
  10.6.7. Key Strategic Moves and Developments
10.7. Japan Lifeline
  10.7.1. Company Overview
  10.7.2. Key Executives
  10.7.3. Company Snapshot
  10.7.4. Operating Business Segments
  10.7.5. Product Portfolio
  10.7.6. Business Performance
  10.7.7. Key Strategic Moves and Developments
10.8. Teleflex Incorporated
  10.8.1. Company Overview
  10.8.2. Key Executives
  10.8.3. Company Snapshot
  10.8.4. Operating Business Segments
  10.8.5. Product Portfolio
  10.8.6. Business Performance
  10.8.7. Key Strategic Moves and Developments
10.9. St. Jude Medical Inc
  10.9.1. Company Overview
  10.9.2. Key Executives
  10.9.3. Company Snapshot
  10.9.4. Operating Business Segments
  10.9.5. Product Portfolio
  10.9.6. Business Performance
  10.9.7. Key Strategic Moves and Developments
10.10. Lepu Medical Technology (Beijing) Co., Ltd
  10.10.1. Company Overview
  10.10.2. Key Executives
  10.10.3. Company Snapshot
  10.10.4. Operating Business Segments
  10.10.5. Product Portfolio
  10.10.6. Business Performance
  10.10.7. Key Strategic Moves and Developments
10.11. MicroPort Scientific Corporation
  10.11.1. Company Overview
  10.11.2. Key Executives
  10.11.3. Company Snapshot
  10.11.4. Operating Business Segments
  10.11.5. Product Portfolio
  10.11.6. Business Performance
  10.11.7. Key Strategic Moves and Developments